Clinical Trials in San Diego

Showing 13241-13260 of 14,679 trials

A Study to Evaluate Cutaneous Scar Quality Following Bilateral Breast Reduction With the PEAK PlasmaBlade 4.0

NCT01284491

The objective of this clinical study is to evaluate scar quality following incision with the PEAK PlasmaBlade 4.0 using the Patient and Observer Scar Assessment Scale (POSAS), and to compare these results to equivalently-aged scars formed following incision with a standard scalpel.

Macromastia

Medtronic Surgical Technologies13 participantsStarted Jan 2011

San Diego, California, United States

COMPLETEDPhase 3< 1 mile

Iressa Expanded Access Program (EAP)

NCT00034879

A program for patients with non small cell lung cancer who may benefit from Iressa, but cannot enter another clinical trial due to them not being eligible, or for whom no trials are available.

CarcinomaNon-small-cell LungMetastases+1 more

AstraZenecaStarted Aug 2000

Alabaster, Alabama, United States • Anniston, Alabama, United States • Birmingham, Alabama, United States +623 more locations

A Study to Evaluate Cutaneous Scar Quality Following Bilateral Breast Reduction With the PEAK PlasmaBlade 4.0

Iressa Expanded Access Program (EAP)

Find Trials by Condition in San Diego

Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania

Seroquel in Bipolar Depression Versus SSRI

Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression

A Study in Erectile Dysfunction

A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis.

Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia

PEAK PlasmaBlade TnA Versus Traditional Electrosurgery in Subcapsular Tonsillectomy

Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550

PEAK PlasmaBlade 4.0 in Bilateral Breast Reduction

S9912 Combination Chemo in Stage III Ovarian Cancer,

Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia

S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer

A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer

CAFE Comparison of Atypicals in First Episode of Psychosis

Study of Antidepressants in Parkinson's Disease

Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With Sunitinib

Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC)